Wellgistics Health, Inc. Income Statement
WGRX|2 years of annual SEC 10-K data (FY2024-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 2 fiscal years. All figures from audited SEC 10-K filings.
Wellgistics Health, Inc. reported $18M in revenue and $7M in net loss for FY2025. Revenue increased 0.0% from FY2024 to FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.55 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Revenue | $18.1M | $18.1M |
| Cost of Revenue | $16.4M | $16.4M |
| Gross Profit | $1.8M | $1.8M |
| SG&A Expense | $6.8M | $2.9M |
| Operating Income | -$6.1M | -$2.9M |
| Net Income | -$6.9M | -$2.9M |
| EPS (Basic) | -$0.15 | -$0.06 |
| EPS (Diluted) | -$0.15 | -$0.06 |
| Shares Outstanding | 51.1M | 44.7M |
| Gross Margin | 9.8% | 9.8% |
| Operating Margin | -33.9% | -15.9% |
| Profit Margin | -37.8% | -16.0% |